These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 27860208)

  • 1. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ
    Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.
    Michna E; Blonsky ER; Schulman S; Tzanis E; Manley A; Zhang H; Iyer S; Randazzo B
    J Pain; 2011 May; 12(5):554-62. PubMed ID: 21429809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
    Nalamachu SR; Pergolizzi J; Taylor R; Slatkin NE; Barrett AC; Yu J; Bortey E; Paterson C; Forbes WP
    Pain Pract; 2015 Jul; 15(6):564-71. PubMed ID: 24815199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.
    Viscusi ER; Barrett AC; Paterson C; Forbes WP
    Reg Anesth Pain Med; 2016; 41(1):93-8. PubMed ID: 26650429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of subcutaneous methylnaltrexone in the treatment of opioid-induced constipation: a responder post hoc analysis.
    Michna E; Weil AJ; Duerden M; Schulman S; Wang W; Tzanis E; Zhang H; Yu D; Manley A; Randazzo B
    Pain Med; 2011 Aug; 12(8):1223-30. PubMed ID: 21810165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone.
    Webster LR; Israel RJ
    J Pain Res; 2018; 11():2509-2516. PubMed ID: 30425563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
    Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
    Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.
    Anissian L; Schwartz HW; Vincent K; Vincent HK; Carpenito J; Stambler N; Ramakrishna T
    J Hosp Med; 2012 Feb; 7(2):67-72. PubMed ID: 21998076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
    Webster LR; Michna E; Khan A; Israel RJ; Harper JR
    Pain Med; 2017 Aug; 18(8):1496-1504. PubMed ID: 28810695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension.
    Bull J; Wellman CV; Israel RJ; Barrett AC; Paterson C; Forbes WP
    J Palliat Med; 2015 Jul; 18(7):593-600. PubMed ID: 25973526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
    Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
    J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
    Hale M; Wild J; Reddy J; Yamada T; Arjona Ferreira JC
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):555-564. PubMed ID: 28576452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
    Lipman AG; Karver S; Cooney GA; Stambler N; Israel RJ
    J Pain Palliat Care Pharmacother; 2011; 25(2):136-45. PubMed ID: 21657861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
    Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Webster LR; Yamada T; Arjona Ferreira JC
    Pain Med; 2017 Dec; 18(12):2350-2360. PubMed ID: 28371937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
    Webster L; Diva U; Tummala R; Sostek M
    Pain Pract; 2018 Apr; 18(4):505-514. PubMed ID: 28898536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients.
    Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.